Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CareMiBrain is a South Korean medical technology company specializing in the development of high-resolution, dedicated brain Positron Emission Tomography (PET) systems. Spun out from the Korea Advanced Institute of Science and Technology (KAIST), the company's flagship product is a compact PET scanner designed specifically for brain imaging, allowing for the early diagnosis and monitoring of neurodegenerative diseases such as Alzheimer's and Parkinson's. Unlike traditional whole-body PET scanners, CareMiBrain's technology offers significantly higher sensitivity and spatial resolution while maintaining a smaller footprint and lower cost. The system is uniquely designed to allow patients to remain in a sitting position during scans, improving comfort and accessibility for elderly patients. CareMiBrain aims to revolutionize molecular brain imaging by making advanced diagnostic tools more available to clinical and research institutions worldwide.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CareMiBrain.